Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Prescription required for orders placed from the USA Supartz is a sterile, non-pyrogenic solution of purified sodium hyaluronate. It is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately fo conservative non-drug therapy and simple pain medications (eg. tylenol)
Supartz is given by intra-articular (into the joint) injection BY YOUR PHYSICIAN once a week for a total of 5 injections. All Injections must be injected by a practitioner who has medical and specialist training. The practitioner must be medically qualified.
Each 2.5ML prefilled syringe contains sodium hyaluronate 25.0mg, sodium chloride 21.25mg, dibasic sodium phosphate dodecahydrate 1.343mg, sodium dihydrogen phosphate dihydrate 0.04mg, water for injection,
Store in the original packaging below 77 degrees F (25 degrees C). DO NOT FREEZE. Do not use after expiration date on package. STRICT ASEPTIC ADMINISTRATION TECHNIQUE MUST BE FOLLOWED. THIS MEDICATION MUST BE ADMINISTERED BY YOUR PHYSICIAN. Discard any unused Supartz. The prefilled syringe is intended for single use. The content of the syringe must be used immediately once the container has been opened.